Ardian recently announced it has entered exclusive talks with Equistone Partners Europe to take ownership of Unither Pharmaceuticals in a transaction valued at around €675m. Alice Tchernookova reports
If Ardian’s €675m deal for Unither Pharmaceuticals is brought to completion as planned in Q1 2017, the new capital structure will see the GP take a majority share in the company. Company management,...
Deal marks the second bolt-on for the business, following the acquisition of Swiss diagnostic imaging provider IRD
Deal marks the second investment made from the GP's 2016-vintage sixth vehicle, which closed on £660m
Acquisition is the company's first out of two planned for this year with ActoMezz's backing
Total commitments for the fund fell some way short of the vehicle's €350m target and €400m hard-cap